Global Pharmaceuticals, Biotechnology & Life Sciences
Global Pharmaceuticals, Biotechnology & Life Sciences industry profile is an essential resource for top-level data and analysis covering the Pharmaceuticals, Biotechnology & Life Sciences industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
The global pharmaceuticals, biotechnology, and life sciences industry group is composed of the pharmaceuticals market, the biotechnology market, and the life sciences tools and services market.
The pharmaceuticals market includes only ethical drugs for human consumption, ex-factory prices (the value at which manufacturers sell the drugs to distributors).
The biotechnology market profile reviews companies primarily involved in the development, manufacturing or marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding. Both medical and non-medical biotech products are included.
The life sciences tools & services market is comprised of companies enabling the drug discovery, development and production continuum by providing analytical tools, instruments, consumables & supplies, clinical trial services and contract research services. However, the market value in this profile only includes revenues from contract research services, clinical and non-clinical, from firms primarily servicing the pharmaceutical and biotechnology industries.
Any currency conversions have been made at constant annual average exchange rates.
For the purposes of this report, the global market consists of North America, South America, Western Europe, Eastern Europe, Asia-Pacific and rest of the World.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of Global Pharmaceuticals, Biotechnology & Life Sciences’s recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of Global Pharmaceuticals, Biotechnology & Life Sciences
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
- Market shares are covered by manufacturer or brand
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
The global pharmaceuticals, biotechnology, and life sciences industry group is composed of the pharmaceuticals market, the biotechnology market, and the life sciences tools and services market.
The pharmaceuticals market includes only ethical drugs for human consumption, ex-factory prices (the value at which manufacturers sell the drugs to distributors).
The biotechnology market profile reviews companies primarily involved in the development, manufacturing or marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding. Both medical and non-medical biotech products are included.
The life sciences tools & services market is comprised of companies enabling the drug discovery, development and production continuum by providing analytical tools, instruments, consumables & supplies, clinical trial services and contract research services. However, the market value in this profile only includes revenues from contract research services, clinical and non-clinical, from firms primarily servicing the pharmaceutical and biotechnology industries.
Any currency conversions have been made at constant annual average exchange rates.
For the purposes of this report, the global market consists of North America, South America, Western Europe, Eastern Europe, Asia-Pacific and rest of the World.
Contents
EXECUTIVE SUMMARYMARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Novartis AG
Pfizer Inc.
Roche Holding AG
Sanofi-Aventis SA
MARKET FORECASTS
Market value forecast
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting
LIST OF TABLES
Table 1: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09
Table 2: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009
Table 3: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009
Table 4: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009
Table 5: Novartis AG: key facts
Table 6: Novartis AG: key financials ($)
Table 7: Novartis AG: key financial ratios
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: key financials ($)
Table 10: Pfizer Inc.: key financial ratios
Table 11: Roche Holding AG: key facts
Table 12: Roche Holding AG: key financials ($)
Table 13: Roche Holding AG: key financials (CHF)
Table 14: Roche Holding AG: key financial ratios
Table 15: Sanofi-Aventis SA: key facts
Table 16: Sanofi-Aventis SA: key financials ($)
Table 17: Sanofi-Aventis SA: key financials (€)
Table 18: Sanofi-Aventis SA: key financial ratios
Table 19: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14
LIST OF FIGURES
Figure 1: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09
Figure 2: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009
Figure 3: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009
Figure 4: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009
Figure 5: Forces driving competition in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 6: Drivers of buyer power in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 7: Drivers of supplier power in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 11: Novartis AG: revenues & profitability
Figure 12: Novartis AG: assets & liabilities
Figure 13: Pfizer Inc.: revenues & profitability
Figure 14: Pfizer Inc.: assets & liabilities
Figure 15: Roche Holding AG: revenues & profitability
Figure 16: Roche Holding AG: assets & liabilities
Figure 17: Sanofi-Aventis SA: revenues & profitability
Figure 18: Sanofi-Aventis SA: assets & liabilities
Figure 19: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14
Skip to top